Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 9, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07869238). This is a study registration, not published results. Lead sponsor: Neumous Inc.. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 10 participants (ESTIMATED). Conditions: Alzheimer's Disease, Blood Brain Barrier. Interventions: DEVICE: NMS-01. Primary outcome measures: Proportion of subjects with successful BBB opening (%) , Change from baseline at 1day and 7day; Proportion of successful BBB opening relative to the number of targets within the application site(%) , Change from baseline at Day 1 and Day 7; Accuracy of BBB opening location relative to the pre-targeting location(%) , Time Frame: Change from baseline at Day 1 and Day 7; BBB recovery or not at 24 hours (±6 hours) or 7 days(%) , Time Frame: Change from baseline at Day 1 and Day 7; Adverse events recording , up to Day 7. Brief summary: A single-center, single-arm, prospective, open-label, pilot clinical trial to evaluate the safety and efficacy of the Focused ultrasound stimulator system (NMS-01) for transient Blood-Brain Barrier (BBB) opening in patients with mild to moderate Alzheimer's disease